Number of Byetta® Lawsuits Filed Across the Nation Continues to Grow
According to a recent report, several lawsuits against Byetta® are being filed in federal courts nationwide, all involving similar allegations that the drug manufacturers failed to sufficiently warn about the risks and the importance of monitoring during treatment.
Byetta®, a type 2 diabetes drug, is an injectable diabetes medication that is administered twice daily through a self-contained device colloquially described as a “pen.” Introduced in 2005, Byetta® was the first drug of its class to receive FDA approval. It was soon followed by other similar type 2 diabetes injectable medications, including Januvia®, Janumet®, and Victoza®.
In April of this year, the Judicial Panel on Multidistrict Litigation (JPML) received a request to consolidate all pancreatic cancer lawsuits filed in various federal district courts by people alleging such injuries after using Byetta®, Victoza®, Januvia®, and Janumet®. The JPML is scheduled to hear oral arguments in order to decide whether these cases should be consolidated for purposes of a multi-district litigation (MDL) during the next hearing session taking place on July 25, 2013 in Portland, Maine.
Legal Disclaimer: The choice of a lawyer is an important decision and should not be based solely on advertisements.